Basilea Pharmaceutica Ltd (0QNA)
LSE
65.80
+0.50 (+0.77%)
Closed
Oct 7, 2026
Day's Range
64.5066.00
52 wk Range
44.7070.40
Financial Statements - 0QNA - Basilea Pharmaceutica Ltd
Revenue
73.90M▲ 171.1%
Net Income
66.48M▲ 164.0%Net Margin 90.0%
Free Cash Flow
-561.69K▼ 100.3%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 73.90M | -103.99M | -7.76M | -10.95M |
| Cost of Goods | - | - | - | - |
| Gross Profit | - | - | - | - |
 Operating Expense | - | - | - | - |
| Operating Income | - | - | - | - |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 66.48M | -103.85M | -6.88M | -9.16M |
| Income Tax | - | - | 0 | 0 |
| Net Income | 66.48M | -103.85M | -6.88M | -9.16M |
| EPS Basic | 0.9 | -1.49 | -0.1 | -0.13 |
| EPS Diluted | 0.83 | -1.49 | -0.1 | -0.13 |
| Basic Shares Outstanding | 74.15M | 69.80M | 68.83M | 71.37M |
| Diluted Shares Outstanding | 74.15M | 69.80M | 68.83M | 71.37M |
| Ebit | - | - | - | - |
| Ebitda | - | - | - | - |
| Net Income Continuous Operations | 66.48M | -103.85M | -6.88M | -9.16M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
